Gisondi, Paolo, Francesco Loconsole, Paola Raimondo, and Roberto Ravasio. “Cost Per Responder for Risankizumab Vs Secukinumab in Patients With Moderate-to-Severe Plaque Psoriasis in Italy”. Global and Regional Health Technology Assessment 8, no. 1 (September 6, 2021): 120–130. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2258.